North America Rapid Diagnostic Tests (RDT) Market to 2032
Overview
The North America Rapid Diagnostic Tests (RDT) Market is expected to reach a 31.47 USD Billion by 2032 and is projected to grow at a CAGR of 13.84% from 2025 to 2032.
Revenue, 2024 (USD Billion)
15.33
Forecast, 2032 (USD Billion)
31.47
CAGR, 2024 - 2032
13.84%
Report Coverage
North America
North America Rapid Diagnostic Tests (RDT) Market 2018-2032 USD Billion
North America Rapid Diagnostic Tests (RDT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 15.33 USD Billion
- Projected Market Size (2032): 31.47 USD Billion
- CAGR (2025-2032): 13.84%
Key Findings of North America Rapid Diagnostic Tests (RDT) Market
- The North America Rapid Diagnostic Tests (RDT) Market was valued at 15.33 USD Billion in 2024.
- The North America Rapid Diagnostic Tests (RDT) Market is likely to grow at a CAGR of 13.84% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adult in Age Group Segment accounted for the largest share of the market with a revenue of 12.99 USD Billion
- The fastest growing segment Infections Disease Testing in Application Segment grew Fastest with a CAGR of 16.68% during the forecast period from 2024 to 2032.
North America Rapid Diagnostic Tests (RDT) Market Scope
North America Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Mode
- Over-the-Counter
- Professional
Product Type
- Others
- Instruments
- Consumables and Kits
Age Group
- Pediatric
- Adult
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
North America Rapid Diagnostic Tests (RDT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 15.33 USD Billion |
| Market Value in 2032 | 31.47 USD Billion |
| CAGR (2025-2032) | 13.84% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, End User, Specimen, Application, Approach, Test Type, Technology, Mode, Product Type, Age Group, Modality |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 15.33 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 13,595.86 USD Million in 2024.
Segments and Scope
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 9.47 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.77 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By End User
- Hospital & Clinic is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 8.38 USD Billion in the year 2024.
- Hospital & Clinic is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.66 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Specimen
- Swab is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.92 USD Billion in the year 2024.
- Swab is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.58 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Application
- Infections Disease Testing is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 5.21 USD Billion in the year 2024.
- Infections Disease Testing is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.68 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Approach
- In-Vitro Diagnostic is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 11.36 USD Billion in the year 2024.
- In-Vitro Diagnostic is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.36 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Test Type
- Determining Confirmation is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.74 USD Billion in the year 2024.
- Determining Confirmation is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.57 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Technology
- PCR-Based is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 5.73 USD Billion in the year 2024.
- PCR-Based is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.88 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Mode
- Professional is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 11.66 USD Billion in the year 2024.
- Professional is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.14 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Product Type
- Consumables and Kits is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 8.63 USD Billion in the year 2024.
- Consumables and Kits is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.47 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Age Group
- Adult is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 12.99 USD Billion in the year 2024.
- Adult is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.11 % in forecast period 2025-2032.
-
North America Rapid Diagnostic Tests (RDT) Market to 2032, By Modality
- Laboratory Based Test is the largest segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 10.92 USD Billion in the year 2024.
- Laboratory Based Test is the Fastest growing segment in North America Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.22 % in forecast period 2025-2032.
North America Rapid Diagnostic Tests (RDT) Market Company Share Analysis
| Company Name |
|
||
| PerkinElmer Inc. | |||
| Quidel Corporation | |||
| Bio-Rad Laboratories, Inc. | |||
| Cardinal Health | |||
| Abbott | |||
North America Rapid Diagnostic Tests (RDT) Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Rapid Diagnostic Tests (RDT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Specimen, Application, Approach, Test Type, Technology, Mode, Product Type, Age Group, Modality.
North America Rapid Diagnostic Tests (RDT) Market was valued at USD 15.33(Revenue in USD Billion) in 2020.
North America Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 13.84% during the forecast period of 2024 to 2032.
The Adult segment is expected to dominate the North America Rapid Diagnostic Tests (RDT) Market, holding a largest market share of 12.99 USD Billion in 2024
Coming Soon....
North America Rapid Diagnostic Tests (RDT) Market Scope
North America Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Research And Academic Institutes
- Home Care Setting
- Others
- Diagnostic Laboratory
- Hospital & Clinic
Specimen
- Others
- Sputum
- Saliva
- Urine
- Blood
- Swab
Application
- Others
- Toxicology Testing
- Pregnancy & Fertility Testing
- Drugs-Of-Abuse Testing
- Cardiometabolic Testing
- Oncology Testing
- Cardiology Testing
- Glucose Monitoring
- Infections Disease Testing
Approach
- Molecular Diagnostic
- In-Vitro Diagnostic
Test Type
- Viral Sequencing
- Serological Testing
- Determining Confirmation
Technology
- Others
- Substrate Technology
- Microfluidics
- Agglutination Assay
- Lateral Flow Immunochromatographic Assays
- Flow-Through Assays
- PCR-Based
Mode
- Over-the-Counter
- Professional
Product Type
- Others
- Instruments
- Consumables and Kits
Age Group
- Pediatric
- Adult
Modality
- Non-Laboratory Based Test
- Laboratory Based Test
Frequently Asked Questions
The North America Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Specimen, Application, Approach, Test Type, Technology, Mode, Product Type, Age Group, Modality.
North America Rapid Diagnostic Tests (RDT) Market was valued at USD 15.33(Revenue in USD Billion) in 2020.
North America Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 13.84% during the forecast period of 2024 to 2032.
The estimated market value of the North America Rapid Diagnostic Tests (RDT) Market for final year is USD 31.47 (USD Billion).
North America Rapid Diagnostic Tests (RDT) Market Company Profiling
Frequently Asked Questions
The North America Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Distribution Channel, End User, Specimen, Application, Approach, Test Type, Technology, Mode, Product Type, Age Group, Modality.
North America Rapid Diagnostic Tests (RDT) Market was valued at USD 15.33(Revenue in USD Billion) in 2020.
North America Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 13.84% during the forecast period of 2024 to 2032.
The estimated market value of the North America Rapid Diagnostic Tests (RDT) Market for final year is USD 31.47 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.